Biotech Values

[mcbio]

MYL is merely the US regulatory and distribution arm for the Copaxone knockoff Natco sells in India. I don’t think this drug stands a chance of getting FDA approval as a generic version of Copaxone.

Hmmm. This sounds quite similar to another situation I can think of. ; )

Which do you give the better chance of receiving approval: Teva's generic Lovenox or MYL's generic Copaxone (let's make this apples-to-apples in some sense and assume that NVS/MNTA/MYL succeed on the Copaxone patent litigation)?